Abstract

BackgroundGenetic variants in inflammation-related genes have been associated with biliary stones and biliary tract cancers in previous studies.MethodsTo follow-up on these findings, we examined 35 single nucleotide polymorphism (SNPs) in 5 genes related to inflammation (IL8, NFKBIL, RNASEL, TNF, and VEGFA) in 456 participants with incident biliary tract cancer cases (262 gallbladder, 141 extrahepatic bile duct, 53 ampulla of Vater), 982 participants with biliary stones, and 860 healthy controls in a population–based case–control study in Shanghai, China.ResultsSuggestive associations were observed for SNPs in VEGFA with biliary stones, IL8 with gallbladder and ampulla of Vater cancers, and RNASEL with ampulla of Vater cancer (false discovery rate≤0.2).ConclusionThese findings provide additional support for the role of inflammation in biliary stones and biliary tract cancer risk and need further validation.

Highlights

  • Genetic variants in inflammation-related genes have been associated with biliary stones and biliary tract cancers in previous studies

  • Of the 35 SNPs examined, statistically significant (p

  • We extended the analysis of common genetic variants to approximately 80% coverage for VEGFA, 90% for RNASEL and 75% for IL8, none of the overall effects for each of the tested genes resulted in significant associations at the 0.05 level with either biliary stones or cancer

Read more

Summary

Introduction

Genetic variants in inflammation-related genes have been associated with biliary stones and biliary tract cancers in previous studies. Previous clinical and population-based studies have linked various inflammatory factors and mechanisms with the development of biliary tract cancers [3,4,5,6]. Data from our population-based study of biliary tract cancers in Shanghai suggested that variants in PTGS2 [10], IL8, IL8RB, RNASEL, NOS2 and VEGF were associated with biliary tract cancer and/or stones [11]. To follow-up on these initial findings, in this analysis we examined an additional 28 SNPs in four of the candidate genes we previously identified (IL8, RNASEL, TNF, and VEGFA) in our population-based study in Shanghai. We evaluated five SNPs in NFKBIL, a novel gene in the major histocompatibility complex (MHC) class I region that was not evaluated previously

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.